JP2016539148A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539148A5
JP2016539148A5 JP2016536528A JP2016536528A JP2016539148A5 JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5 JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5
Authority
JP
Japan
Prior art keywords
alkyl
group
optionally substituted
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016536528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539148A (ja
JP6457523B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/075890 external-priority patent/WO2015082324A1/en
Publication of JP2016539148A publication Critical patent/JP2016539148A/ja
Publication of JP2016539148A5 publication Critical patent/JP2016539148A5/ja
Application granted granted Critical
Publication of JP6457523B2 publication Critical patent/JP6457523B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016536528A 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン Expired - Fee Related JP6457523B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13195720 2013-12-04
EP13195720.1 2013-12-04
PCT/EP2014/075890 WO2015082324A1 (en) 2013-12-04 2014-11-28 Sulfoximine substituted quinazolines for pharmaceutical compositions

Publications (3)

Publication Number Publication Date
JP2016539148A JP2016539148A (ja) 2016-12-15
JP2016539148A5 true JP2016539148A5 (https=) 2017-11-30
JP6457523B2 JP6457523B2 (ja) 2019-01-23

Family

ID=49726564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536528A Expired - Fee Related JP6457523B2 (ja) 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン

Country Status (7)

Country Link
US (1) US10093660B2 (https=)
EP (1) EP3077383B1 (https=)
JP (1) JP6457523B2 (https=)
AU (1) AU2014359456B2 (https=)
CA (1) CA2929742C (https=)
ES (1) ES2693520T3 (https=)
WO (1) WO2015082324A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3140300B1 (en) * 2014-05-07 2019-08-14 Evotec International GmbH Sulfoximine substituted quinazolines for pharmaceutical compositions
UY38540A (es) * 2019-01-14 2020-08-31 Pi Industries Ltd Compuestos de fenilamidina 3-sustituida, preparación y uso
CN112812136B (zh) * 2019-11-15 2022-04-12 武汉光谷亚太医药研究院有限公司 新型2,3-二氢化茚衍生化合物、制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987192A (en) 1974-01-07 1976-10-19 The Upjohn Company Compositions and process of treatment
US5602118A (en) 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
US5750471A (en) 1994-06-08 1998-05-12 E. I. Du Pont De Nemours And Company Cyclic sulfonamide herbicides
SE0102147D0 (sv) 2001-06-18 2001-06-18 Pharmacia Ab New methods
WO2003037362A2 (en) 2001-10-29 2003-05-08 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
BR0308162A (pt) 2002-03-01 2004-12-07 Pfizer Derivados de indolil-uréia de tienopiridinas úteis como agentes antiangiogênicos e métodos para o seu uso
GB0315587D0 (en) 2003-07-03 2003-08-13 Univ Dundee Anti-inflammatory assay and compounds
KR101151932B1 (ko) 2004-04-08 2012-06-01 다우 아그로사이언시즈 엘엘씨 살충성 n-치환된 설폭시민
EP1746099A1 (en) 2004-12-23 2007-01-24 DeveloGen Aktiengesellschaft Mnk1 or Mnk2 inhibitors
EP1899353A1 (en) * 2005-06-22 2008-03-19 DeveloGen Aktiengesellschaft Thienopyrimidines for pharmaceutical compositions
CA2646429A1 (en) 2006-03-09 2007-09-13 Pharmacopeia, Inc. 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
CA2651898A1 (en) * 2006-04-07 2007-10-18 Develogen Aktiengesellschaft Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
CA2654358A1 (en) 2006-06-22 2007-12-27 Biovitrum Ab (Publ) Pyridine and pyrazine derivatives as mnk kinase inhibitors
DE102007024470A1 (de) 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren
EP2152672A1 (en) * 2007-05-24 2010-02-17 Bayer Schering Pharma Aktiengesellschaft Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
EP2500340A1 (en) 2008-01-25 2012-09-19 Syngenta Participations AG. 2-Cyanophenyl Sulfonamide Derivatives Useful as Pesticides
US20120232073A1 (en) 2009-11-23 2012-09-13 Santhosh Francis Neelamkavil Fused bicyclic pyrimidine derivatives and methods of use thereof
EP2539343B1 (en) 2010-02-26 2015-12-30 Evotec International GmbH Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
UY33241A (es) * 2010-02-26 2011-09-30 Boehringer Ingelheim Int ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
AR088082A1 (es) 2011-10-13 2014-05-07 Lilly Co Eli Moduladores selectivos del receptor androgeno
WO2014072244A1 (en) * 2012-11-09 2014-05-15 Boehringer Ingelheim International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
DK3013805T3 (en) * 2013-06-28 2018-04-23 Evotec Int Gmbh Sulfoximine-substituted quinazolines and their use as MNK1 and / or MNK2 kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2013518107A5 (https=)
JP2013542247A5 (https=)
JP2016510326A5 (https=)
JP2015508103A5 (https=)
JP2013542261A5 (https=)
JP2015511609A5 (https=)
JP2014511891A5 (https=)
JP2014518286A5 (https=)
JP2017528503A5 (https=)
JP2014511892A5 (https=)
JP2016503797A5 (https=)
JP2014528464A5 (https=)
JP2015536986A5 (https=)
JP2018537535A5 (https=)
HK1210771A1 (zh) 氮杂吲哚衍生物
JP2017518360A5 (https=)
JP2013518036A5 (https=)
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral
JP2018525425A5 (https=)
JP2015516419A5 (https=)
JP2016515550A5 (https=)
RU2015135824A (ru) Бициклические соединения пиримидона в качестве ингибиторов lp-pla2
JP2016539148A5 (https=)
JP2021503451A5 (https=)
RU2018117499A (ru) Производные 6-[5-амино-6-(2-этоксиэтокси)-имидазо[4,5-b]пиридин-3-ил]никотинонитрила и их применение в качестве irak ингибиторов